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Background: Antimicrobial drug resistance is a global issue that affects health, economic, and 
social development. The problem has been attributed to misuse of antimicrobial agents.
Purpose: To identify the agents of bacterial infection in Ghana, determine their antibiogram, 
and the possibility of setting up a surveillance program.
Patients and methods: A prospective quantitative study set in various hospitals including 
two teaching hospitals, seven regional hospitals, and two district hospitals in Ghana. A total of 
5099 bacterial isolates from various clinical specimens were collected over a period of 1 year, 
including data related to the patients. Susceptibility of the isolates was determined by the Kirby–
Bauer method. In addition, the minimum inhibitory concentration (MIC) of multidrug-resistant 
isolates of epidemiological significance was also determined using the E-test.
Results: A wide range of bacterial isolates were identified in both teaching and regional 
hospitals. High percentage of resistance was observed for tetracycline (82%), cotrimoxazole 
(73%), ampicillin (76%), and chloramphenicol (75%). Multidrug resistance was observed to 
a combination of ampicillin, tetracycline, chloramphenicol, and cotrimoxazole. On the other 
hand, a lower percentage of resistance was observed for ceftriaxone (6.3%), ciprofloxacin (11%), 
and amikacin (9.9%).
Conclusion: Generally, the prevalence of multidrug resistance was widespread among the 
various isolates. Some multidrug-resistant strains of Staphylococcus aureus, Salmonella typhi, 
and non-typhoidal Salmonella (NTS) had high MIC to cefuroxime (.256), gentamicin (.256), 
and ciprofloxacin (.32).
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Introduction
Bacterial infections constitute an important cause of morbidity and mortality among 
humans all over the world. For decades, antimicrobial drugs have proven useful for the 
treatment of bacterial infections. Although some bacteria are inherently resistant to even 
newly developed antimicrobial agents, the emergence of acquired resistance to anti-
microbial drugs has been observed in almost all pathogenic bacteria.1,2 Antimicrobial 
resistance has become an important public health problem associated with serious 
consequences for the treatment of infection. This ultimately affects both economic and 
social development. The problem has been attributed to the misuse of antimicrobial 
drugs, which provide selective pressure, favoring the emergence of resistant strains. 
To contain the problem of antimicrobial resistance, the World Health Organiza-
tion has provided some interventions. These include creating a national task force, 
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and designing reference microbiological facilities that would 
coordinate effective surveillance of antimicrobial resistance 
among   common pathogens.3 While these interventions seem 
to have been well implemented in the developed world, lack 
of resources constrain implementation in many developing 
countries where treatment options also tend to be relatively 
limited. Thus, although a global problem, antimicrobial 
resistance tends to be more significant in developing countries 
than in the developed world.
Several studies in African countries have reported the 
  presence of resistant strains of bacteria, including reports from 
Nigeria,4 Uganda,5 Tanzania,6 Zimbabwe,7 and Ghana,8–14 all 
showing high levels of resistance to antimicrobial agents. 
Most of these reports show bacterial resistance to commonly 
utilized and relatively cheap drugs like ampicillin, tetracy-
cline, and cotrimoxazole, which have been the mainstay of 
antimicrobial treatment in Africa for decades.
In Ghana, antimicrobial therapy constitutes a major form 
of treatment. It is mainly empirical due to a relative lack of 
appropriate laboratory facilities for culture and susceptibility 
testing of bacteria in several health facilities. Even where 
laboratory facilities are available, culture and susceptibility 
tests may not be requested due to the fact that this is an extra 
cost to be paid by the patient. In Ghana, drug resistance has 
mainly been reported from the two teaching hospitals in 
Accra and Kumasi, Korle-Bu (KBTH)8–11 and Komfo Anokye 
(KATH),12,13 respectively, and hardly any from regional and 
district hospitals. Thus, there is inadequate information on 
the susceptibility of microorganisms to antimicrobial agents 
used for treatment in several areas in Ghana. Syndromic 
treatment has been established for infections such as sexually 
transmitted diseases and respiratory tract infections. Without 
surveillance records of antimicrobial susceptibility, empirical 
treatment could be ineffective and expensive. The objectives 
of this study were to identify the agents of bacterial infections, 
the prevalence and trend of bacterial drug resistance, and 
assess the possibility of setting up a laboratory-based 
surveillance program in Ghana.
Material and methods
study area and collection  
of bacteria isolates
The study was carried out in eleven hospitals and covered 
nine of the ten regions in Ghana; the study hospitals included 
two teaching hospitals, seven regional hospitals, and two 
district hospitals. Arrangements were made with the study 
hospitals for collection and storage of bacteria isolated from 
clinical specimens of patients, including cerebrospinal fluid, 
blood, urine, wound swabs, sputum, and high vaginal swabs. 
Fastidious bacteria were stored in Trypticase soy broth with 
glycerol at 4°C, while non-fastidious bacteria were stored 
on nutrient agar slopes at 4°C. The stored isolates were 
transported at regular intervals to KBTH in Accra or KATH 
in Kumasi for analysis. In KBTH and KATH, isolates were 
tested by standard procedures, and those collected from 
the other hospitals were retested by standard procedures at 
KBTH. Over a period of 1 year (December 2002–December 
2003) a total of 5099 isolates from various clinical specimens 
were collected from the hospitals.
Laboratory analysis
Laboratory tests on isolates involved biochemical identifi-
cation and susceptibility testing. Firstly, the isolates were 
identified by culture and biochemical tests. Following this, the 
Kirby–Bauer method of susceptibility testing15 was employed 
to determine the antibiogram of the isolates using the follow-
ing 16 antimicrobial drugs with their disk   content in micro-
grams (µg): ampicillin (10), tetracycline (30),   cotrimoxazole 
(25), chloramphenicol (30), gentamicin (30), amikacin (30), 
cefuroxime (30), cefotaxime (30), ceftriaxone (30), penicil-
lin (10), erythromycin (15), cloxacillin (5), ciprofloxacin (5), 
norfloxacin (10), nalidixic acid (30), and nitrofurantoin (300), 
all commonly used in Ghana. Additionally, the E-test was 
used to determine the MIC of selected isolates identified as 
multidrug resistant. Such bacteria included S. aureus, S. typhi, 
and non-typhoidal Salmonella (NTS). The minimum inhibi-
tory concentrations (MICs) were presented as the minimum 
inhibition concentration for 50% and 90% of isolates, MIC50 
and MIC90, respectively. The commercial antimicrobial discs 
and E-strips used were purchased from Oxoid Ltd (Basing-
stoke, UK) and AB Biodisk (Solna,   Sweden), respectively.
Data analysis
Laboratory results and data collected on patients were entered 
into Microsoft Excel and analyzed in Stata (v 7.0; Stata 
Corp, College Station, TX) to address the objectives of the 
study. Frequencies and prevalence rates were calculated for 
resistant and multidrug-resistant bacteria agents, including 
their antibiogram, and comparisons were made between 
teaching and regional hospitals.
Results
From December 2002 to December 2003, a total of 5099 
isolates from various clinical specimens were collected Infection and Drug Resistance 2011:4 submit your manuscript | www.dovepress.com
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from the hospitals and comprised mainly Gram-negative 
organisms. The most prevalent organism in the collection was 
Escherichia coli, followed by S. aureus, Klebsiella spp, and 
Pseudomonas aeruginosa. These four organisms made up 
56% of the organisms studied, as listed in Table 1. Most of the 
bacteria from the regions were of the enterobacteria group, eg, 
E. coli and Klebsiella ssp., in addition to Pseudomonas and 
S. aureus. A more varied group of organisms were isolated 
from the teaching hospitals, where the   laboratories were able 
to grow fastidious microorganisms such as Haemophilus, 
Neisseria, and Streptococcus pneumoniae. For most of the 
fastidious organisms, the number of isolates studied was 
relatively few, and no anaerobic bacteria were collected.
Figure 1 shows the overall prevalence of resistance to the 
antimicrobial agents tested. There was very high resistance 
to cotrimoxazole (73%), chloramphenicol (75%), ampicillin 
(76%), and tetracycline (82%). The teaching and regional 
hospitals presented a mixed percentage prevalence of isolates 
resistant to the different antimicrobials tested (Figure 2). 
The overall resistance of some older drugs like tetracycline, 
cotrimoxazole, ampicillin, and chloramphenicol was higher 
in the regional hospitals compared to the teaching hospitals 
(P . 0.05). On the other hand, the prevalence of isolates 
resistant to the quinolones, penicillin, cloxacillin, and eryth-
romycin, was higher in the teaching hospitals compared with 
the regional hospitals (P . 0.05; Figure 2).
Table 2 shows the prevalence of multidrug-resistant 
strains of different types of bacteria, including E. coli (69.5%), 
Enterobacter species (60.4%), S. typhi (62.4%), Citrobacter 
(65%), and S. aureus (42.3%). Table 3 summarizes the 
MIC50 and MIC90 values of S. aureus, S. typhi, and NTS 
to selected antimicrobials. Full resistance to ciprofloxacin 
was not observed for S. typhi and NTS in the isolates tested. 
However, for cefuroxime and gentamicin, the MIC90 were 
generally high. For example, the MIC90 for S. aureus, S. typhi, 
and NTS were all .256 µg/mL−1 (Table 3).
The biochemical identification of the organisms collected 
from the regions was comparable to those retested in KBTH. 
Out of a total of 387 isolates from nonteaching or regional 
and district hospitals, 150 (39%) had similar susceptibility 
results, but the others showed discrepancies ranging from 
53% to 75%.
Discussion
Bacteria causing infections from various specimens in 
Ghana were identified as including E. coli, S. aureus, 
Klebsiella, Pseudomonas, and Salmonella species. Most of 
the isolates from the regions were Gram-negative rods, eg, 
enterobacteria and Pseudomonas. The fastidious organisms 
like Streptococcus pneumoniae, Neisseria gonorrhoeae, and 
Haemophilus species were isolated only from the teaching 
hospitals. The inability to isolate fastidious organisms in 
some of the hospitals was due to lack of particular or special 
media and other requirements for culture and identification, 
or due to lack of technical expertise.
The prevalence of drug resistance among the bacteria was 
high. Four antimicrobial agents had very high prevalence 
of resistance, namely tetracycline (82%), ampicillin (76%), 
chloramphenicol (75%), and cotrimoxazole (73%), and for 
these drugs, the prevalence of resistance is higher in the 
regions than in the teaching hospitals. In addition, these are 
drugs that have been reported as having high-percentage resis-
tance for a number of microorganisms for several years.16,17 
The rate of resistance had been rising over the years, not only 
for clinical isolates but also for the normal intestinal flora of 
the healthy population.16 Lower prevalence of resistance was 
found for gentamicin (28%), cefuroxime (27%), cefotaxime, 
and norfloxacin (20%). The lowest prevalence of resistance of 
between 6%–10% was found in ciprofloxacin, amikacin, and 
ceftriaxone. These are drugs which have been on the Ghanaian 
market for a relatively short period of time compared to drugs 
like ampicillin and chloramphenicol. In addition, ciprofloxa-
cin, amikacin, and ceftriaxone are very expensive drugs and 
are usually prescribed for serious infections. This might be 
one of the reasons for the relatively low levels of resistance. 
Table 1 Bacterial isolates obtained from teaching, regional and 
district hospitals from ghana (n = 5099)
Bacterial agent n (%)
Escherichia coli 1105 (21.7)
Staphylococcus aureus 788 (15.5)
Klebsiella spp 536 (10.5)
Pseudomonas aeruginosa 441 (8.7)
Proteus spp 397 (7.8)
Enterobacter spp 275 (5.4)
Non-typhoidal Salmonella 247 (4.8)
Other Streptococcus spp 127 (2.5)
Citrobacter spp 120 (2.4)
Salmonella typhi 109 (2.1)
Acinetobacter spp 88 (1.7)
Streptococcus pneumoniae 51 (1.0)
Neisseria gonorrhoeae 17 (0.3)
Neisseria meningitidis 11 (0.02)
Haemophilus influenzae 4 (0.08)
Shigella spp 4 (0.08)
Vibrio cholerae 1 (0.02)
Others 778 (15.4)Infection and Drug Resistance 2011:4 submit your manuscript | www.dovepress.com
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The resistant profiles observed in this study are similar to 
those reported by a relatively recent study in 2008.14 In that 
study, the authors observed low prevalence of resistance to 
ciprofloxacin, amikacin, and ceftriaxone, as in the current 
study. This suggests that the resistance profiles of these drugs 
have not changed significantly over the 5-year period between 
the two studies. It must be noted, however, that resistance to 
the fluoroquinolones, such as ciprofloxacin and ofloxacin, has 
been rising in several countries.18 Recently, the mechanism 
of quinolone resistance has been shown to be associated with 
upregulation of efflux pumps, which export quinolones and 
other antimicrobials out of the bacterial cell.19 Additionally, 
mutations in the quinolone resistance-determining regions 
(QRDRs) of gyrA and parC are also common resistance 
mechanisms indicating that resistance to one fluoroquinolone 
may extend to other fluoroquinolones.19,20 It is therefore neces-
sary to control the use of these agents so as to maintain their 
effectiveness for a longer period.
Resistance to antimicrobial agents is a bacteria char-
acteristic carried on genes. The resistance genes present 
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Figure 1 Prevalence of resistance among antimicrobial drugs from teaching, regional, and district hospitals in ghana (n = 5099).
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in intestinal flora are transferable to pathogenic bacteria in 
the intestines. Plasmid-mediated resistance is more easily 
transferred than chromosomal genes. Mills-Robertson et al 
reported the location of plasmids in Salmonella on conjuga-
tive plasmids.21 The plasmids could have evolved because of 
antibiotic misuse. There is antibiotic misuse by the general 
public due to easy availability of drugs without prescription, 
or by physicians, through poor prescribing habits.
This study did not differentiate between organisms from 
community-acquired infections and those from hospital 
infections. A study in Kenya showed that organisms from 
the community and those from hospital infections had the 
same patterns of multidrug resistance.22 It may be necessary 
in future to compare the susceptibility of community and 
hospital isolates of bacteria.
In view of the low numbers of some organisms like 
Haemophilus, Neisseria, and Vibrio species, it was difficult 
to comment adequately on their findings. It may, therefore, 
be necessary to collect more data in future and analyze 
the results. Although very few isolates of N. gonorrhoeae 
were received, studies in other African countries show that 
resistant strains are endemic in Africa.23 All these studies 
demonstrate that local surveillance is necessary to help 
in decision making in relation to syndromic treatment 
and implementation of control measures. In view of the 
discrepancies in the susceptibility results from the various 
hospitals, it will be inappropriate to start collecting sus-
ceptibility reports for surveillance purposes.   Standardized 
methods of susceptibility testing must be used in all labo-
ratories before laboratory-based surveillance can be used 
in Ghana.
In the current study, the MIC90 for cefuroxime and gen-
tamicin against S. aureus and S. typhi exceeded 256 µg/mL. 
These microorganisms are highly resistant, and this gives 
cause for concern. Therefore, there is a need for a bigger 
study of MICs of epidemiologically significant clinical 
isolates in Ghana.
There are certain limitations to this study. In the period 
2002–2003, patients were required to pay for the cost of their 
investigations; invariably, only a relatively small portion of 
all cases with an infection had cultures taken to determine 
the causative agent and its drug susceptibility. In addition, 
when an infection seemed to be serious, it was more likely to 
be investigated, especially if the patient was not responding 
to treatment. Ideally, one needs to investigate many episodes 
of a particular infection to determine the types of causative 
agent(s). Anaerobic bacteria were not collected from any 
of the hospitals. Although KBTH and KATH had trained 
personnel, they were unable to culture anaerobes. This is 
due to the fact that it is very expensive to acquire Gas Pak 
systems to generate an anaerobic environment for the culture 
of anaerobes.
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Table 2 Prevalence of multidrug resistance among bacterial agents 
isolated from teaching, regional and district hospitals in ghana
Bacteria Number Multidrug-resistant   
isolates n (%)
Pseudomonas aeruginosa 441 100 (22.7)
Other Streptococcus spp 127 100 (78.7)
Acinetobacter spp 88 57 (64.8)
Citrobacter spp 120 78 (65.0)
Streptococcus pneumoniae 51 4 (7.8)
Escherichia coli 1105 768 (69.5)
Enterobacter spp 275 166 (60.4)
Salmonella typhi 109 68 (62.4)
Non-typhoidal Salmonella 247 149 (60.3)
Klebsiella spp 536 309 (57.6)
Proteus spp 397 222 (55.9)
Neisseria gonorrhoeae 17 2 (11.8)
Staphylococcus aureus 788 333 (42.3)
Table 3 Minimum inhibitory concentration (µg/mL) of selected 
isolates for cefuroxime, gentamicin and ciprofloxacin
Organism/ 
antimicrobial agent
n MIC range 
μg/mL
MIC50 MIC90
Staphylococcus aureus 18
  cefuroxime 0.25–256 4.0 .256
  gentamicin 0.19–256 2.0 .256
Salmonella typhi 10
  cefuroxime 1.5–256 3.0 .256
  gentamicin 0.19–1.5 0.38 0.75
  Ciprofloxacin 0.004–0.094 0.016 0.064
Non-typhoidal Salmonella 14
  cefuroxime 3.0–256 4.0 .256
  gentamicin 0.25–4.0 0.75 3.0
  Ciprofloxacin 0.004–32 0.012 0.25
Note:  Disc  concentration  (µg/mL)  of  e-strips  of  cefuroxime,  gentamicin  and 
ciprofloxacin used were 0.023–256, 0.023–256 and 0.002–32, respectively. 
Abbreviation: MIc50 and MIc90, minimum inhibition concentration for 50% and 
90% of the isolates, respectively.Infection and Drug Resistance
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